A desirable monoclonal antibody, an effective cytotoxic drug, and a suitable linker make up antibody-drug conjugates (ADCs). A suitable linker between the antibody and the cytotoxic drug creates a clear bridge, enabling the antibody to precisely deliver the cytotoxic drug to tumor sites and deliver it only to tumor cells. In addition to conjugation, the linkers preserve the stability of ADCs during their preparation, storage, and systemic circulation phases.
The linkers found in the ADCs currently undergoing clinical evaluation are primarily divided into two groups: cleavable and noncleavable. Cleavable linkers rely on internal cellular mechanisms to release the toxin, such as cytoplasmic reduction, exposure to acidic conditions in the lysosome, or cleavage by particular cellular proteases. For the release of the cytotoxic molecule with noncleavable linkers, the antibody portion of the ADC must be broken down by proteolytic enzymes while retaining the linker and the amino acid by which it was attached to the antibody.
Based on knowledge of the internalization and breakdown of the antibody-target antigen complex and a comparison of the preclinical in vitro and in vivo activities of conjugates, the choice of linker depends on the target. Additionally, because each molecule has different chemical restrictions and frequently the drug structure lends itself to a particular linker, the choice of a linker is also influenced by the type of cytotoxin used.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V76783 | Mc-Gly-Gly-Phe-Gly-PAB-OH TFA (Mc-GGFG-PAB-OH TFA) | Mc-Gly-Gly-Phe-Gly-PAB-OH (Mc-GGFG-PAB-OH) TFA is a cleavable ADC (Antibody-drug conjugate) linker that may be utilized to prepare active antibody conjugated molecules (ADC). | |
![]() |
V56383 | MC-Gly-Gly-{D-Phe}-Gly-NH-CH2-O-CH2COOH | 1802520-40-6 | MC-Gly-Gly-{D-Phe}-Gly-NH-CH2-O-CH2COOH is a cleavable (degradable) ADC (Antibody-drug conjugate) linker that may be utilized to prepare active antibody conjugated molecules (ADC). |
![]() |
V79587 | Mc-Leu-Gly-Arg | 2639874-49-8 | Mc-Leu-Gly-Arg is a cleavable ether linker that can be used for antibody conjugation active molecules (ADC) research. |
![]() |
V54619 | MC-PEG2-C2-NHSester | 1263044-56-9 | MC-PEG2-C2- NHS ester is a non-degradable linker containing 2 PEG (polyethylene glycol) units, which may be utilized to prepare active ADC molecules. |
![]() |
V56380 | MC-PEG2-NH2 | 640267-62-5 | MC-PEG2-NH2 is a degradable (non-cleavable (non-degradable)) ADC bridge used for the synthesis of antibody active molecule conjugates (ADCs). |
![]() |
V25127 | Mc-Val-Ala-PAB | 1870916-87-2 | Mc-Val-Ala-PAB is a cleavable (degradable) ADC (Antibody-drug conjugate) linker that may be utilized to prepare active antibody conjugated molecules (ADC). |
![]() |
V5177 | MC-Val-Cit-PAB | 159857-80-4 | MC-Val-Cit-PAB is a novel cathepsin cleavable ADC linker that is utilized for the synthesis of antibody-drug conjugate (ADC) such as some of the FDA approved ADC drugs including brentuximab vedotin. |
![]() |
V52695 | MC-Val-Cit-PAB-NH-C2-NH-Boc | 1616727-22-0 | MC-Val-Cit-PAB-NH-C2-NH-Boc is an ADC (Antibody-drug conjugate) Linker that can be degraded by cathepsin and may be utilized to prepare ADC molecules. |
![]() |
V54682 | MC-VC-PAB-NH2 TFA | 1616727-21-9 | MC-VC-PAB-NH2 TFA is a cleavable (degradable) ADC (Antibody-drug conjugate) linker that may be utilized to prepare Antibody-drug conjugates (ADC). |
![]() |
V85092 | mc-vc-PAB-PBD | 2088364-36-5 | |
![]() |
V34833 | MCC | 104676-09-7 | MCC is a non-cleavable (non-degradable) ADC linker that may be utilized to prepare ADCs, like MCC-DM1. |
![]() |
V80745 | Me-PMeOx(100)-N3 (MW 8.5kDa) | Me-PMeOx(100)-N3 (MW 8.5kDa) is a reagent for click chemistry. | |
![]() |
V80746 | Me-PMeOx(50)-N3 (MW 4.3kDa) | Me-PMeOx(50)-N3 (MW 4.3kDa) is a reagent for click chemistry. | |
![]() |
V76134 | Me-Tet-PEG2-COOH | 2741759-99-7 | Me-Tet-PEG2-COOH is an ADC (Antibody-drug conjugate) Linker containing 2 PEG (polyethylene glycol) units. |
![]() |
V76143 | Me-Tet-PEG2-NHS | 2740357-12-2 | Me-Tet-PEG2-NHS is an ADC (Antibody-drug conjugate) Linker containing 2 PEG (polyethylene glycol) units. |
![]() |
V76125 | Me-Tet-PEG3-Maleimide | 2141976-31-8 | Me-Tet-PEG3-Maleimide is an ADC (Antibody-drug conjugate) Linker containing 3 PEG (polyethylene glycol) units. |
![]() |
V79991 | Me-Tet-PEG3-NH2 | Me-Tet-PEG3-NH2 is an ADC (Antibody-drug conjugate) Linker containing 3 PEG (polyethylene glycol) units. | |
![]() |
V76112 | Me-Tet-PEG3-NHBoc | 2141976-32-9 | Me-Tet-PEG3-NHBoc is an ADC (Antibody-drug conjugate) Linker containing 3 PEG (polyethylene glycol) units. |
![]() |
V76127 | Me-Tet-PEG4-COOH | 2141976-30-7 | Me-Tet-PEG4-COOH is an ADC (Antibody-drug conjugate) Linker containing 4 PEG (polyethylene glycol) units. |
![]() |
V76114 | Me-Tet-PEG4-Maleimide | 1715913-76-0 | Me-Tet-PEG4-Maleimide is an ADC (Antibody-drug conjugate) Linker containing 4 PEG (polyethylene glycol) units. |